200 related articles for article (PubMed ID: 24114819)
1. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis.
Zhang W; Li C; Liu B; Wu R; Zou N; Xu YZ; Yang YY; Zhang F; Zhou HM; Wan KQ; Xiao XQ; Zhang X
Ann Hepatol; 2013; 12(6):892-900. PubMed ID: 24114819
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.
Zhang W; Xu YZ; Liu B; Wu R; Yang YY; Xiao XQ; Zhang X
ScientificWorldJournal; 2014; 2014():603409. PubMed ID: 24558317
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
5. Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats.
Frantz EDC; Medeiros RF; Giori IG; Lima JBS; Bento-Bernardes T; Gaique TG; Fernandes-Santos C; Fernandes T; Oliveira EM; Vieira CP; Conte-Junior CA; Oliveira KJ; Nobrega ACL
Exp Physiol; 2017 Sep; 102(9):1208-1220. PubMed ID: 28626963
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
7. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.
Paizis G; Tikellis C; Cooper ME; Schembri JM; Lew RA; Smith AI; Shaw T; Warner FJ; Zuilli A; Burrell LM; Angus PW
Gut; 2005 Dec; 54(12):1790-6. PubMed ID: 16166274
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
Cao X; Yang F; Shi T; Yuan M; Xin Z; Xie R; Li S; Li H; Yang JK
Sci Rep; 2016 Feb; 6():21592. PubMed ID: 26883384
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis.
Huang Q; Xie Q; Shi CC; Xiang XG; Lin LY; Gong BD; Zhao GD; Wang H; Jia NN
Int J Mol Med; 2009 Jun; 23(6):717-23. PubMed ID: 19424597
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.
Gowrisankar YV; Clark MA
J Neurochem; 2016 Jul; 138(1):74-85. PubMed ID: 27085714
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
13. Relationship between renal injury and the antagonistic roles of angiotensin-converting enzyme (ACE) and ACE2.
Ma C; Xin H; Jiang XY; Wang YX; Zhang YS
Genet Mol Res; 2014 Apr; 13(2):2333-42. PubMed ID: 24781988
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice.
Liu R; Qi H; Wang J; Wang Y; Cui L; Wen Y; Yin C
Exp Physiol; 2014 Apr; 99(4):651-63. PubMed ID: 24414175
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats.
Figueiredo VP; Barbosa MA; de Castro UGM; Zacarias AC; Bezerra FS; de Sá RG; de Lima WG; Dos Santos RAS; Alzamora AC
Oxid Med Cell Longev; 2019; 2019():5868935. PubMed ID: 31396301
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone.
Ali RM; Al-Shorbagy MY; Helmy MW; El-Abhar HS
Eur J Pharmacol; 2018 Jul; 831():68-76. PubMed ID: 29715453
[TBL] [Abstract][Full Text] [Related]
17. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
18. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice.
Chen LN; Yang XH; Nissen DH; Chen YY; Wang LJ; Wang JH; Gao JL; Zhang LY
Shock; 2013 Nov; 40(5):420-9. PubMed ID: 23903854
[TBL] [Abstract][Full Text] [Related]
20. Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice.
Moraes DS; Lelis DF; Andrade JMO; Meyer L; Guimarães ALS; De Paula AMB; Farias LC; Santos SHS
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106501. PubMed ID: 33049402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
